These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6131701)

  • 1. T lymphocytes in schizophrenia.
    Coffey CE; Sullivan JL; Rice JR
    Biol Psychiatry; 1983 Jan; 18(1):113-9. PubMed ID: 6131701
    [No Abstract]   [Full Text] [Related]  

  • 2. [T- and B-lymphocytes and their clinico-pathogenetic significance in patients with paranoid schizophrenia].
    Saĭfulina NA; Arkhipov GS; Stepanov AF; Gusev IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):87-90. PubMed ID: 1979461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppressor T-lymphocytes in continuously progressive juvenile schizophrenia].
    Maznina TP; Mikheeva TV; Lavrov VF; Abramova LI; Koliaskina GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1065-9. PubMed ID: 6236659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the functional activity of T-lymphocytes after administration of stelazine].
    Androsova LV; Sekirina TP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):87-9. PubMed ID: 1684460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Status of the T-lymphocyte system of immunity in patients with newly diagnosed paroxysmal schizophrenia].
    Rogozhnikova OA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):47-9. PubMed ID: 1661515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of the changes in the indicators of the T-system of immunity in patients with newly diagnosed paroxysmal progressive schizophrenia during its treatment].
    Rogozhnikova OA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):42-5. PubMed ID: 1686698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
    Baskak SC; Ozsan H; Baskak B; Devrimci Ozgüven H; Kinikli G
    Turk Psikiyatri Derg; 2008; 19(1):5-12. PubMed ID: 18330738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Features of the manifestations of cellular and humoral immune responses in schizophrenia of different durations].
    Ismailov NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1353-5. PubMed ID: 6976665
    [No Abstract]   [Full Text] [Related]  

  • 9. [Schizophrenia and immunity].
    Galinowski A; Levy-Soussan P; Lôo H
    Ann Med Psychol (Paris); 1992; 150(2-3):138-42. PubMed ID: 1364190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients.
    McAllister CG; Rapaport MH; Pickar D; Paul SM
    Arch Gen Psychiatry; 1989 Oct; 46(10):956-7. PubMed ID: 2572208
    [No Abstract]   [Full Text] [Related]  

  • 11. [B-lymphocytes of the blood in schizophrenia: effect of psychotropic therapy].
    Potapova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1378-81. PubMed ID: 2866649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the immunomodulator levamisole in the complex treatment of juvenile schizophrenics with an unfavorable course].
    Mikheeva TV; Sekirina TP; Abramova LI; Koliaskina GI; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(1):109-13. PubMed ID: 2881414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-lymphocyte subpopulations in schizophrenic patients.
    Henneberg A; Riedl B; Dumke HO; Kornhuber HH
    Eur Arch Psychiatry Neurol Sci; 1990; 239(5):283-4. PubMed ID: 1971787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indices of autoimmunity in schizophrenic patients with an unfavorable course after long-term treatment with neuroleptics].
    Kupriianova IE; Vasil'ev NV; Krasik ED
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(1):114-8. PubMed ID: 6131563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromediator mechanisms of regulating immune reactions in schizophrenics].
    Aliev NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1382-5. PubMed ID: 2866650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of levamisole in the combined therapy of patients with slowly progressing juvenile schizophrenia].
    Sekirina TP; Mikheeva TV; Koliaskina GI; Tsutsul'kovskaia MIa; Orlova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(7):90-4. PubMed ID: 2973198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-immunological characteristics of schizophrenia patients based on neurocytotoxic test data].
    Semenov SF; Vilkov GA; Siziakina LP; Kogan RD; Mogilina NP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1069-73. PubMed ID: 6332442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment.
    Maino K; Gruber R; Riedel M; Seitz N; Schwarz M; Müller N
    Psychiatry Res; 2007 Aug; 152(2-3):173-80. PubMed ID: 17448544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is dopamine related to immunologic changes in schizophrenic patients?
    Kerepcić I; Bamburac J; Jurin M
    Ann N Y Acad Sci; 1987; 496():737-9. PubMed ID: 2886098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.